Skip to content
healthcare.dev

Dasatinib

NDC 66993-233, dasatinib, tablet, from Prasco Laboratories.

Product NDC
66993-233
Status
Listed
Labeler
Prasco Laboratories
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021986
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-233 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB20 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
66993-233-60669930233601 BOTTLE in 1 CARTON (66993-233-60) / 60 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1931e73f-918c-4d69-9543-de9643513d05

Use it

Look up 66993-233 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-233 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-233. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.